ProShare Advisors’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-704,513
| Closed | -$70M | – | 1836 |
|
|
2019
Q3 | $70M | Buy |
704,513
+38,887
| +6% | +$3.7M | 0.39% | 82 |
|
|
2019
Q2 | $61.5M | Sell |
665,626
-101,695
| -13% | -$9.66M | 0.37% | 85 |
|
|
2019
Q1 | $72.4M | Sell |
767,321
-3,369
| -0.4% | -$295K | 0.43% | 81 |
|
|
2018
Q4 | $49.4M | Buy |
770,690
+73,347
| +11% | +$5.41M | 0.35% | 85 |
|
|
2018
Q3 | $62.4M | Sell |
697,343
-84,311
| -11% | -$7.45M | 0.42% | 78 |
|
|
2018
Q2 | $62.1M | Sell |
781,654
-87,618
| -10% | -$7.27M | 0.42% | 77 |
|
|
2018
Q1 | $77.5M | Buy |
869,272
+76,031
| +10% | +$7.3M | 0.51% | 43 |
|
|
2017
Q4 | $82.8M | Buy |
793,241
+230,190
| +41% | +$26M | 0.57% | 36 |
|
|
2017
Q3 | $82.1M | Buy |
563,051
+42,924
| +8% | +$5.85M | 0.75% | 21 |
|
|
2017
Q2 | $67.5M | Buy |
520,127
+49,254
| +10% | +$6.04M | 0.67% | 30 |
|
|
2017
Q1 | $58.6M | Sell |
470,873
-41,355
| -8% | -$4.95M | 0.61% | 53 |
|
|
2016
Q4 | $59.3M | Buy |
512,228
+43,581
| +9% | +$4.85M | 0.66% | 35 |
|
|
2016
Q3 | $49M | Sell |
468,647
-158,337
| -25% | -$17.1M | 0.68% | 57 |
|
|
2016
Q2 | $61.8M | Buy |
626,984
+17,002
| +3% | +$1.76M | 0.8% | 21 |
|
|
2016
Q1 | $61.1M | Sell |
609,982
-211,498
| -26% | -$21.8M | 0.84% | 20 |
|
|
2015
Q4 | $98.4M | Buy |
821,480
+82,803
| +11% | +$9.58M | 1.19% | 10 |
|
|
2015
Q3 | $79.9M | Sell |
738,677
-2,847
| -0.4% | -$353K | 1.12% | 10 |
|
|
2015
Q2 | $85.8M | Sell |
741,524
-53,358
| -7% | -$6.1M | 1.19% | 8 |
|
|
2015
Q1 | $91.6M | Buy |
794,882
+67,562
| +9% | +$8.07M | 1.08% | 10 |
|
|
2014
Q4 | $81.4M | Buy |
727,320
+175,918
| +32% | +$18.6M | 0.95% | 15 |
|
|
2014
Q3 | $52.3M | Sell |
551,402
-36,227
| -6% | -$3.27M | 0.69% | 21 |
|
|
2014
Q2 | $50.5M | Sell |
587,629
-130,407
| -18% | -$9.92M | 0.65% | 20 |
|
|
2014
Q1 | $50.1M | Buy |
718,036
+219,964
| +44% | +$17.4M | 0.63% | 22 |
|
|
2013
Q4 | $42.1M | Buy |
498,072
+179,200
| +56% | +$14.2M | 0.63% | 25 |
|
|
2013
Q3 | $24.5M | Sell |
318,872
-40,670
| -11% | -$2.85M | 0.58% | 21 |
|
|
2013
Q2 | $21M | Buy |
+359,542
| New | +$21.6M | 0.41% | 42 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
ProShare Advisors's CELG Position: Q4 2019 in Review
ProShare Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 704,513 shares — an estimated $70M sold.
ProShare Advisors first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $98.4M in Q4 2015. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- ProShare Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- ProShare Advisors sold 704,513 Celgene Corp shares in Q4 2019, an estimated $70M.
- ProShare Advisors first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- ProShare Advisors's Celgene Corp position peaked at $98.4M in Q4 2015.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on ProShare Advisors's 13F filing for Q4 2019, filed 12 Feb 2020.